BlackRock, Inc. 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-07 2:58 pm Sale |
2022-09-30 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
BLACKROCK INC BLK |
1,115,027 2.800% |
-1,994,643 (-64.14%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
BLACKROCK INC BLK |
3,109,670 7.700% |
3,109,670 (New Position) |
Filing |